Saarbrücken, September 24, 2024. The pharmaceutical manufacturer URSAPHARM has expanded its “concept for healthy eyelids”. The comprehensive and coordinated therapeutic approach for the individual treatment and care of lid margin inflammation (blepharitis) and meibomian gland dysfunction has been complemented by the product EvoTears® OMEGA eye drops. The extended treatment concept includes products for heat treatment, […]
Find out moreCompany
News from the company
URSAPHARM provides holistic therapy concept for healthy eyelids
New design, easier handling – URSAPHARM relaunches POSIFORLID® eye mask
Saarbrücken, July 9, 2024. New design, easier handling – URSAPHARM relaunches POSIFORLID® eye mask for the treatment of blepharitis and dysfunction of the glands of the eyelids. The pharmaceutical manufacturer URSAPHARM has revised the POSIFORLID® eye mask – the medical device has a new design and is easier to use. The contents of the self-heating […]
Find out moreURSAPHARM Arzneimittel GmbH turns 50
Saarbrücken, 8. April 2024. Celebrating half a century of innovation: URSAPHARM Arzneimittel turns 50 URSAPHARM’s company story began in 1974 and is inextricably linked with healthcare in Saarland. In the 1970s, four pharmacists named Albrecht Holzer, Dieter Trox, Werner Buxmann and Werner Bernhard realised that there was a need to treat eye disease in Saarland population, […]
Find out moreURSAPHARM becomes partner of FIS Ski Jumping World Cup
Saarbrücken, 24 November 2023. FIS is pleased to announce that URSAPHARM Arzneimittel GmbH and its premium brand HYLO® will join the FIS Ski Jumping World Cup family as its presenting partner through the 2023-2025 seasons. The HYLO® product family is Germany’s market leader for eye drops and ointments to alleviate the symptoms of dry eyes. […]
Find out moreURSAPHARM extends POSIFORLID® portfolio with eyelid hygiene wipes
Saarbrücken, 25 April 2022. Saarbrücken-based pharmaceutical company URSAPHARM is extending its POSIFORLID® product portfolio with eyelid hygiene wipes for treating …
Find out moreNew Partnership Expands Scope’s Dry Eye Portfolio with the launch of the OPTASE® HYLO® range of dry eye products in the USA from June 2021.
New York, N.Y. – May 17, 2021 – Scope Eyecare and URSAPHARM Arzneimittel GmbH have been partners collaborating in the European dry eye sector for nearly 12 years. An exciting new partnership for the US paves the way for the next phase of this partnership with the creation and launch of a co-branded range of […]
Find out more德国海露®全新包装中国上市
HYLO COMOD® is the star product of HYLO® product range. It was launched in Germany in 1999 and since years HYLO COMOD® is the market leading eye care product in Germany and Europe. For more than 20 years, we insist on production in German and supply to the World, and now sell well in 74 […]
Find out moreURSAPHARM becomes EYE CARE partner of FC Bayern München
On the occasion of the press conference in Munich on 16-08-2017 the URSAPHARM company proclaimed the new “golden” partnership with the FC Bayern München. Besides the managing director and shareholder Dominik Holzer and the executive director of sales and marketing Christian Krensel the managing directors of the FC Bayern München, M. Karl-Heinz Rummenigge and M. Andreas Jung answered to the questions of the numerous representatives of the media.
Find out moreExclusive world premiere of the URSAPHARM Virtual Reality Experience on the occasion of the AAD 2017
On 13-03-2017, at the beginning of this year’s ophthalmological specialist conference AAD in Düsseldorf, the URSAPHARM company presented exclusively the “Eye-Explorer Virtual Reality” App for the first time.
Find out more
Read the latest product updates, information and company news from URSAPHARM Arzneimittel GmbH or find out about the most recent research findings. We will always keep you up to date on innovations and developments in the company.